pylori for uninvestigated dyspepsia. Level of evidence C, Grade of recommendation 1 Experts’ opinions: completely
agree (51.7%), mostly agree (34.5%), partially agree (6.9%), mostly disagree (3.5%), completely disagree (3.5%), Selleck Romidepsin not sure (0%) In Western countries, a test-and-treat strategy for H. pylori infection has been recommended as a safe, cost-effective initial approach for young patients with uninvestigated dyspepsia and without alarm symptoms.[13, 48] In a meta-analysis, the test-and-treat strategy for H. pylori infection as an initial approach to uninvestigated dyspepsia was more cost-effective, and not significantly different in symptom improvement when compared with an early endoscopy. However, early endoscopy is recommended as an initial approach to uninvestigated dyspepsia instead of a test-and-treat strategy of H. pylori infection in Asia (including Korea, China,
and Japan), where the prevalence rate of gastric cancer is very high (0.9–3.4%) and the average age of incidence is low.[50, 51] The optimal cut-off age for early endoscopy as an initial approach for patients with uninvestigated dyspepsia varies according to region and ethnicity.[50, 52] In Korea, further studies are needed to determine the appropriate cut-off age for early endoscopy as an initial approach in patients with uninvestigated dyspepsia. Statement 7. H. pylori eradication helps long-term symptom improvement in some patients with functional dyspepsia. Level of evidence A, Grade of recommendation 2 Experts’ opinions: completely Opaganib research buy agree (18.5%), mostly agree (55.6%), partially agree (22.2%), mostly disagree (3.7%), completely disagree (0%), not sure (0%) Studies have shown that an H. pylori eradication group exhibited long-term symptom improvement in functional dyspepsia compared with the placebo group.[53, 54] In a meta-analysis of 17 randomized studies, the risk of symptom persistence was reduced by 9% in the H. pylori eradication group compared with the placebo group,
which was a statistically significant difference. In addition, a prospective study conducted by a primary Racecadotril medical facility showed that H. pylori eradication had a significant impact on symptom improvement in patients with functional dyspepsia. It is not clear whether H. pylori eradication improves functional dyspepsia in Asian populations. Previous studies are insufficient as they have included a small sample size or no randomization protocol. Although a meta-analysis showed 3.6 times greater symptom improvement in the H. pylori eradication group, H. pylori eradication is not cost-effective in all regions. Another analysis of 12 randomized studies showed that H. pylori eradication was a cost-effective treatment for functional dyspepsia. No randomized controlled studies have assessed the effect of H. pylori eradication on functional dyspepsia in Korea. In one prospective study, there was no difference in symptom improvement between the successful H.